Kavuru Vimal 4
4 · Acasti Pharma Inc. · Filed Dec 20, 2023
Insider Transaction Report
Form 4
Kavuru Vimal
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-12-19+10,000→ 10,000 totalExercise: $2.13Exp: 2033-12-19→ Class A Common Shares (10,000 underlying)
Footnotes (1)
- [F1]Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which vest in equal monthly installments over a period of 12 months, provided that 3/12 of the options shall be deemed to have vested upon the date of grant.